Sudhir Valia, brother-in-law of Sun Pharma's Managing Director Dilip Shanghvi, has stepped down from the position of whole-time director but will continue as non-executive director of the company, a regulatory filing said.
The pharma major in a filing on Tuesday said Valia will step down from the position of the company's whole-time director to non-executive, non-independent director from May 29, 2019.
Asked for the reasons for Valia shifting to a non-executive role, a Sun Pharma spokesperson said: "As his personal businesses are increasingly taking more of his time, he has decided to give up the role of a whole-time director in the company."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app